RPA
PFE icon

Redwood Park Advisors’s Pfizer PFE Stock Holding History

Redwood Park Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Buy
986
+15
+2% +$392 0.02% 151
2026
Q1 		$27.3K Sell
971
-20
-2% -$532 0.02% 136
2025
Q4 		$24.7K Sell
991
-822
-45% -$20.7K 0.02% 146
2025
Q3 		$46.2K Buy
1,813
+30
+2% +$740 0.03% 103
2025
Q2 		$43.2K Sell
1,783
-893
-33% -$20.8K 0.03% 107
2025
Q1 		$67.8K Hold
2,676
– – 0.05% 79
2024
Q4 		$71K Buy
+2,676
New +$72.6K 0.05% 81

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Redwood Park Advisors's PFE Position: Q2 2026 in Review

Redwood Park Advisors increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $392 and bringing the position to 986 shares worth $23.7K. The position accounts for 0.02% of the portfolio, ranked #151.

Redwood Park Advisors first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $71K in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Redwood Park Advisors held 986 shares of Pfizer worth $23.7K as of Q2 2026.
  • Redwood Park Advisors bought 15 Pfizer shares in Q2 2026, an estimated $392.
  • Pfizer made up 0.02% of Redwood Park Advisors's portfolio in Q2 2026, its #151 holding.
  • Redwood Park Advisors first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Redwood Park Advisors's Pfizer position peaked at $71K in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.